Skip to content
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Work Medical Technology Group Ltd. WOK

4 fiscal years on record · USD · FY2025 reported · SEC filings only
$9.8M
▼ 14.4% YoY
$-1.1M
$4.9M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 9.8M
Revenue, FY2025 · full 4-year series below
Revenue $M Net income $M
FY2025 · Revenue 9.8 · Net income -1.1
10M20M-2M-3M
20222025
Compound annual growth
−20.6%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−12 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -11.0% · Net -12.2%
2%4%-10%-20%-30%
202220232025
ROE
FY2025 · ROE -6.8%
-10%-20%-30%
202220232025
Three returns, three denominators.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.
Gross margin23.8%
Operating margin-11.0%
Net margin-12.2%
EBITDAUSD -233,312.00

Each USD of equity lost 7 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 4.9
2M4M-5M-10M
202220232025

Total assetsUSD 33.2M
EquityUSD 18.3M
CashUSD 4.1M
Gross debtUSD 6.4M
Net debtUSD 2.3M
Current ratio1.71×

Net debt stands at 13% of equity.

The 4-year record

4 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
WOK, 4-year financial record
Metric 2025202420232022
Revenue $B0.00.00.00.0
Operating income $B−0.0−0.00.00.0
EBITDA $B−0.0−0.00.00.0
Income tax $B0.0−0.00.00.0
Net income $B−0.0−0.00.00.0
Free cash flow $B0.0−0.00.0−0.0
EPS, diluted $−0.04−0.270.010.07
Dividend / sh $◌◌◌◌
Payout % — not applicable: no dividend————
ROE %−6.8−30.31.1◌
Shares out B◌0.010.01◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 14 reconciliationsAUDITED

Reconciled in 4 of the 4 fiscal years we could check. 32 checks were skipped: the balance sheet is not tagged before 2023. 15 checks were skipped: EPS is not tagged before 2022.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inoutside the United States — SEC code F4
Fiscal year endsSeptember 30
SEC categoryemerging growth company
Data on record since2022

Share this section

Download image